| Prostate carcinoma
Zoladex vs Pylarify
Side-by-side clinical, coverage, and cost comparison for prostate carcinoma.Deep comparison between: Zoladex vs Pylarify with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsPylarify has a higher rate of injection site reactions vs Zoladex based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Pylarify but not Zoladex, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Zoladex
Pylarify
At A Glance
SC injection
Every 28 days
GnRH agonist
IV injection
Single dose
PSMA inhibitor imaging agent
Indications
- Prostate carcinoma
- Endometriosis
- Abnormal uterine bleeding
- Breast Carcinoma
- Prostate carcinoma
Dosing
Prostate carcinoma (Stage B2-C) 3.6 mg SC every 28 days starting 8 weeks before radiotherapy, in combination with flutamide, continued during radiation therapy; alternatively, a 10.8 mg depot may follow the initial 3.6 mg depot.
Prostate carcinoma (advanced) 3.6 mg SC every 28 days; intended for long-term administration.
Endometriosis 3.6 mg SC every 28 days for 6 months.
Abnormal uterine bleeding One or two 3.6 mg SC depots given 4 weeks apart; surgery performed at 4 weeks after one depot, or within 2-4 weeks after the second depot.
Breast Carcinoma 3.6 mg SC every 28 days; intended for long-term administration.
Prostate carcinoma 333 MBq (9 mCi) as a single bolus IV injection; initiate imaging approximately 60 minutes after administration; patient should void immediately prior to image acquisition.
Contraindications
- Known hypersensitivity to GnRH, GnRH agonist analogues, or any component of ZOLADEX
- Pregnancy (except when used for palliative treatment of advanced breast cancer)
—
Adverse Reactions
Most common (>10%) in men Hot flashes, sexual dysfunction, decreased erections, lower urinary tract symptoms
Most common (>20%) in women Hot flushes, headache, sweating, acne, emotional lability, depression, decreased libido, vaginitis, breast atrophy, seborrhea, peripheral edema
Serious Tumor flare, ureteral obstruction, spinal cord compression, pituitary apoplexy
Postmarketing Osteoporosis, bone fracture, deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, transient ischemic attack, ovarian cyst, pituitary adenoma, SJS/TEN, DRESS, AGEP, erythema multiforme, psychotic disorders, suicidal ideation, convulsions
Most common (>0.5%) Headache, dysgeusia, fatigue
Serious Hypersensitivity reaction
Pharmacology
ZOLADEX is a synthetic decapeptide analogue of GnRH that inhibits pituitary gonadotropin secretion; chronic administration suppresses serum testosterone in males to castrate levels and reduces serum estradiol in females to postmenopausal levels, leading to regression of hormone-sensitive tumors and accessory sex organ regression.
Piflufolastat F-18 is a PSMA-targeted radioligand that binds to PSMA-expressing cells, including malignant prostate cancer cells that typically overexpress PSMA; fluorine-18 is a positron-emitting radionuclide that enables PET imaging.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Zoladex
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (0/12) · Qty limit (9/12)
No coverage data available for Pylarify.
UnitedHealthcare
Zoladex
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
No coverage data available for Pylarify.
Humana
Zoladex
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (0/3) · Qty limit (2/3)
No coverage data available for Pylarify.
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Zoladex.
No savings programs available for Pylarify.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
ZoladexView full Zoladex profile
PylarifyView full Pylarify profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.